Overview of genetic defects in endocrinopathies in the island of Cyprus; evidence of a founder effect

Genet Test Mol Biomarkers. 2012 Sep;16(9):1073-9. doi: 10.1089/gtmb.2011.0381. Epub 2012 Aug 2.

Abstract

Aim: Hereditary endocrinopathies in Cyprus exhibit evidence of a founder effect and display the influence of past migration patterns. The genetic frequency and mutation pattern of a specific disorder of sex development (DSD), which is classified as 46,XX DSD or 46,XY DSD, and the non-classic form of congenital adrenal hyperplasia (NC-CAH) outline a type of genetic drift.

Results: Not only the high prevalence of the NC-CAH p.V281L mutation but also the rarity of CAH large lesions present a genetic diversity similar to that observed in the Middle Eastern countries. In addition, both the high frequency of the 5-alpha steroid reductase deficiency (5αSRD) IVS1-2A>G mutation and the carrier frequency of the 17-beta hydroxysteroid dehydrogenase 3 (17β-HSD-3) p.R80Q mutation are good examples of a founder effect. p.R80Q can be considered a founder mutation, even though it has been identified in patients of Dutch, Brazilian, and Portuguese origin. This has led to the speculation that it has a Phoenician origin. Phoenicians as ancient traders migrated around 750 BC from present day Syria, Lebanon, and Israel toward Portugal, Spain, and also to nearby Cyprus. While the 5αSRD IVS1-2A>G mutation has already been extensively reported in Turkish patients, it is very common in the Eastern Mediterranean region.

Conclusion: This short article portrays clearly, through specific endocrine genetic disorders, the past migration trends in Cyprus that shaped the present-day gene pool of the Greek-Cypriot population.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adrenal Hyperplasia, Congenital* / epidemiology
  • Adrenal Hyperplasia, Congenital* / genetics
  • Cyprus
  • Disorders of Sex Development* / epidemiology
  • Disorders of Sex Development* / genetics
  • Endocrine System Diseases / classification
  • Endocrine System Diseases / epidemiology*
  • Endocrine System Diseases / genetics*
  • Female
  • Founder Effect*
  • Humans
  • Male
  • White People / genetics*